Kesari S - Search Results

1

Development of NG2 neural progenitor cells requires Olig gene function.

Ligon KL, Kesari S, Kitada M, Sun T, Arnett HA, Alberta JA, Anderson DJ, Stiles CD, Rowitch DH. Ligon KL, et al. Among authors: kesari s. Proc Natl Acad Sci U S A. 2006 May 16;103(20):7853-8. doi: 10.1073/pnas.0511001103. Epub 2006 May 8. Proc Natl Acad Sci U S A. 2006. PMID: 16682644 Free PMC article.

2

The bad seed: PDGF receptors link adult neural progenitors to glioma stem cells.

Kesari S, Stiles CD. Kesari S, et al. Neuron. 2006 Jul 20;51(2):151-3. doi: 10.1016/j.neuron.2006.07.001. Neuron. 2006. PMID: 16846849 Free article. Review.

3

Olig2-regulated lineage-restricted pathway controls replication competence in neural stem cells and malignant glioma.

Ligon KL, Huillard E, Mehta S, Kesari S, Liu H, Alberta JA, Bachoo RM, Kane M, Louis DN, Depinho RA, Anderson DJ, Stiles CD, Rowitch DH. Ligon KL, et al. Among authors: kesari s. Neuron. 2007 Feb 15;53(4):503-17. doi: 10.1016/j.neuron.2007.01.009. Neuron. 2007. PMID: 17296553 Free PMC article.

4

The central nervous system-restricted transcription factor Olig2 opposes p53 responses to genotoxic damage in neural progenitors and malignant glioma.

Mehta S, Huillard E, Kesari S, Maire CL, Golebiowski D, Harrington EP, Alberta JA, Kane MF, Theisen M, Ligon KL, Rowitch DH, Stiles CD. Mehta S, et al. Among authors: kesari s. Cancer Cell. 2011 Mar 8;19(3):359-71. doi: 10.1016/j.ccr.2011.01.035. Cancer Cell. 2011. PMID: 21397859 Free PMC article.

5

"Smad"eningly erratic: target gene methylation determines whether TGFbeta promotes or suppresses malignant glioma.

Kesari S, Jackson-Grusby L, Stiles CD. Kesari S, et al. Dev Cell. 2007 Mar;12(3):324-5. doi: 10.1016/j.devcel.2007.02.008. Dev Cell. 2007. PMID: 17336898 Free article.

6

Molecular pathogenesis of adult brain tumors and the role of stem cells.

Sauvageot CM, Kesari S, Stiles CD. Sauvageot CM, et al. Among authors: kesari s. Neurol Clin. 2007 Nov;25(4):891-924, vii. doi: 10.1016/j.ncl.2007.07.014. Neurol Clin. 2007. PMID: 17964020 Review.

7

Targeted molecular therapy of malignant gliomas.

Kesari S, Ramakrishna N, Sauvageot C, Stiles CD, Wen PY. Kesari S, et al. Curr Oncol Rep. 2006 Jan;8(1):58-70. doi: 10.1007/s11912-006-0011-y. Curr Oncol Rep. 2006. PMID: 16464405

8

Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08).

Wen PY, Yung WK, Lamborn KR, Norden AD, Cloughesy TF, Abrey LE, Fine HA, Chang SM, Robins HI, Fink K, Deangelis LM, Mehta M, Di Tomaso E, Drappatz J, Kesari S, Ligon KL, Aldape K, Jain RK, Stiles CD, Egorin MJ, Prados MD. Wen PY, et al. Among authors: kesari s. Neuro Oncol. 2009 Dec;11(6):853-60. doi: 10.1215/15228517-2009-010. Neuro Oncol. 2009. PMID: 19293394 Free PMC article. Clinical Trial.

9

Molecular imaging of drug transit through the blood-brain barrier with MALDI mass spectrometry imaging.

Liu X, Ide JL, Norton I, Marchionni MA, Ebling MC, Wang LY, Davis E, Sauvageot CM, Kesari S, Kellersberger KA, Easterling ML, Santagata S, Stuart DD, Alberta J, Agar JN, Stiles CD, Agar NY. Liu X, et al. Among authors: kesari s. Sci Rep. 2013 Oct 4;3:2859. doi: 10.1038/srep02859. Sci Rep. 2013. PMID: 24091529 Free PMC article.

10

Targeted molecular therapy of malignant gliomas.

Kesari S, Ramakrishna N, Sauvageot C, Stiles CD, Wen PY. Kesari S, et al. Curr Neurol Neurosci Rep. 2005 May;5(3):186-97. doi: 10.1007/s11910-005-0046-8. Curr Neurol Neurosci Rep. 2005. PMID: 15865884 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

443 results

Search Page

Filters